​

Aclaris Therapeutics Ownership | Who Owns Aclaris Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Aclaris Therapeutics Ownership Summary

Aclaris Therapeutics is owned by 122.55% institutional investors, 2.79% insiders. Bml capital management is the largest institutional shareholder, holding 19.96% of ACRS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.96% of its assets in Aclaris Therapeutics shares.

ACRS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAclaris Therapeutics122.55%2.79%-25.34%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryDiagnostics & Research Stocks49.06%8.59%42.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bml capital management14.25M19.96%$35.34M
Adage capital partners gp9.63M13.49%$23.88M
Vivo capital8.89M12.45%$22.04M
Rock springs capital management lp6.20M8.69%$15.39M
Ra capital management4.67M6.54%$11.57M
Vanguard group4.33M6.06%$10.73M
D. e. shaw3.29M4.61%$8.17M
Janus henderson group2.80M3.92%$6.99M
Marshall wace, llp2.63M3.69%$6.53M
Samsara biocapital2.39M3.34%$5.91M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management14.25M21.95%$35.34M
Vivo capital8.89M2.47%$22.04M
Aldebaran capital1.02M2.40%$2.52M
Stonepine capital management663.40K1.33%$1.65M
Decheng capital2.27M1.21%$5.62M
Samsara biocapital2.39M0.81%$5.91M
Exome asset management389.33K0.73%$965.55K
Logos global management lp2.22M0.64%$5.51M
Rock springs capital management lp6.20M0.59%$15.39M
Aisling capital management lp434.45K0.38%$1.08M

Top Buyers

HolderShares% AssetsChange
Adage capital partners gp9.63M0.04%9.63M
Vivo capital8.89M2.47%8.89M
Ra capital management4.67M0.15%4.67M
Rock springs capital management lp6.20M0.59%3.45M
Janus henderson group2.80M0.00%2.80M

Top Sellers

HolderShares% AssetsChange
Blackrock2.03M0.00%-3.17M
Trium capital llp---1.91M
Stonepine capital management663.40K1.33%-1.80M
Millennium management1.96M0.00%-1.05M
Bain capital life sciences investors---1.00M

New Positions

HolderShares% AssetsChangeValue
Adage capital partners gp9.63M0.04%9.63M$23.88M
Vivo capital8.89M2.47%8.89M$22.04M
Ra capital management4.67M0.15%4.67M$11.57M
Janus henderson group2.80M0.00%2.80M$6.99M
Marshall wace, llp2.63M0.01%2.63M$6.53M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-14.00
Innealta capital-56.00
Cornerstone planning group-580.00
New york state common retirement fund-586.00
Srs capital advisors-1.63K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202410328.75%87,478,91971.89%1222.41%5881.25%25-
Sep 30, 202480-15.79%50,891,462-3.68%711.29%33-19.51%25-32.43%
Jun 30, 202495-3.06%52,834,184-2.94%741.26%41-4.65%37-5.13%
Mar 31, 202498-9.26%54,434,983-6.90%761.13%43-29.51%3944.44%
Dec 31, 2023108-32.92%58,470,532-16.56%820.84%61-28.24%27-25.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.12M1.96%-
Vanguard US Total Market Shares ETF2.12M1.96%-
Vanguard Institutional Extnd Mkt Idx Tr1.05M0.97%42.92K
Xtrackers S&P 500 Swap ETF 1C923.31K0.85%-
SQUAD Aguja Opportunities I500.00K0.70%-
Vanguard Strategic Small-Cap Equity Inv592.57K0.55%-113.94K
Vanguard VIF Small Co Gr470.22K0.44%-168.80K
iShares Biotechnology ETF408.65K0.38%-
Fidelity Extended Market Index389.50K0.36%-2.48K
Vanguard Health Care ETF224.87K0.31%-592.00

Recent Insider Transactions

DateNameRoleActivityValue
Nov 19, 2024Mehra Anand-Buy$1.50M
Aug 05, 2024Leonard Braden Michael-Buy$256.36K
Aug 02, 2024Leonard Braden Michael-Buy$216.40K
Jul 30, 2024Leonard Braden Michael-Buy$226.37K
Jul 31, 2024Leonard Braden Michael-Buy$132.64K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q41-
2024 Q311-
2024 Q210-

ACRS Ownership FAQ

Who Owns Aclaris Therapeutics?

Aclaris Therapeutics shareholders are primarily institutional investors at 122.55%, followed by 2.79% insiders and -25.34% retail investors. The average institutional ownership in Aclaris Therapeutics's industry, Diagnostics & Research Stocks, is 49.06%, which Aclaris Therapeutics exceeds.

Who owns the most shares of Aclaris Therapeutics?

Aclaris Therapeutics’s largest shareholders are Bml capital management (14.25M shares, 19.96%), Adage capital partners gp (9.63M shares, 13.49%), and Vivo capital (8.89M shares, 12.45%). Together, they hold 45.90% of Aclaris Therapeutics’s total shares outstanding.

Does Blackrock own Aclaris Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aclaris Therapeutics.

Who is Aclaris Therapeutics’s biggest shareholder by percentage of total assets invested?

Bml capital management is Aclaris Therapeutics’s biggest shareholder by percentage of total assets invested, with 21.95% of its assets in 14.25M Aclaris Therapeutics shares, valued at 35.34M$.

Who is the top mutual fund holder of Aclaris Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aclaris Therapeutics shares, with 1.96% of its total shares outstanding invested in 2.12M Aclaris Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools